Only patients in Ivabradine demonstrated further improvement in LVESVi (73 AE 15 ml/m 2 to 62 AE 15 ml/m 2 , p = 0.001), LVEDVi (103 AE 19 ml/ m 2 to 95 AE 18 ml/m 2 , p = 0.001), MPI (23% vs 2.7%, p = 0.001), LVEF (29 AE 3.6 to 34.5 AE 5.4%, p = 0.001) and LV Global Strain (À13.3 AE 1.6 to À20.2 AE 4.4%, p = 0.001) while those in the control group did not show any further change. Parameters like E/A, E/A VTI, MPI, E/E' septal and E/E' lateral showed sustained improvement at 6 months only in the ivabradine group -E/A (1.5 AE 0.5 to 1.1 AE 0.3, p = 0.001), E/A VTI (1.6 AE 0.5 to 1.1 AE 0.3, p = 0.001), E/e' septal (11.6 AE 3.3 to 9.5 AE 2.2, p = 0.001), E/e' lateral (11.6 AE 3.2 to 9.8 AE 2.5, p = 0.001).
Brucella myocarditis with ischemic hepatitis and acute kidney injury -A rare presentation
Ankur Gupta *, Krunal Tamakuwala, Nirav Panchani, Jayesh Rawal Dhiraj Hospital, Piparia, Dist., Vadodara, Gujarat 391760, India
A 24-year-old male patient presented with mild epigastric pain for 2 days and fever for one week. Electrocardiogram of the patient was suggestive of ventricular tachycardia with a heart rate of 200/ min. Immediately, the patient was injected IV amiodarone 150 mg as bolus dose. The patient became dyspnoeic and developed frank pulmonary edema after sometime and had to be managed with mechanical ventilator support. 2D echocardiography suggestive of dilated cardiomyopathy which reversed as the patient improved. The brucella IgM antibodies titres were 3.51 (positive > 1.1). Dilated cardiomyopathy was caused by Brucella myocarditis which led to ventricular tachycardia on admission, cardiogenic shock with subsequent development of pulmonary edema and acute renal failure. The cardiogenic shock led to ischemic hepatitis which was possibly accentuated further by the bolus dose of amiodarone. Thus, final diagnosis of Brucella myocarditis with ischemic hepatitis and acute kidney injury was made.
Red cell distribution width in heart failure R. Girish *, Brig K. Narayanan, Avneet Kumar Gupta Dept of Cardiology, Command Hospital Central Command, Lucknow 226002, UP, India
Background: The goal of this study was to evaluate if red cell distribution width (RDW) can serve as a relatively inexpensive diagnostic marker in cases of heart failure (HF) in India, where diagnostic markers such as N Terminal-Pro Brain Natriuretic Peptide (NTP BNP) are expensive.
Methods: This was an cross-sectional observational study conducted from June 2012 to June 2014 in a tertiary care hospital, in which participants aged ≥18 years, after informed consent was divided into two groups: Cases -100 patients with HF diagnosed on the basis of clinical examination, X-ray chest and Echodoppler and Controls -100 patients without HF. Those with conditions which elevate RDW like anemia, arthritis, neoplasia, hypothyroidism, liver disease, and inflammatory bowel disease were excluded. SYSMEX KX 21 Automated Hematology Analyser was used to generate the complete blood count (CBC) report from which RDW was compared between the two groups to evaluate its utility as an independent marker for HF. Results: Out of the 100 patients of HF, 47 had HF with reduced ejection fraction (HFREF) and 53 had HF with preserved ejection fraction (HFPEF). The mean RDW was significantly higher in the HF patients (53.85 AE 5.39 fl) than controls (42.21 AE 1.66 fl). It was also found to be significantly higher in both subgroups -HFREF (56.96 AE 5.18 fl) and HFPEF (51.10 AE 3.88 fl) than that in controls. Using the Spearman's Rho calculator, the value of ''r'' between RDW and LVEF is À0.55996 and the two-tailed value of p is 0 which was statistically significant. Conclusion: RDW is a readily available and relatively inexpensive test which can be carried out in the HF-population. Both HFREF and HFPEF patients were found to have significantly higher RDW than controls. Understanding how and why this marker is associated with HF may provide novel insights into HF pathophysiology. Further investigation is necessary to determine the pathological mechanism of the relationship and its prognostic significance.
Cardiac beriberi presenting as severe PAH with impending congestive heart failure in infants of poor socioeconomic background Introduction: Severe pulmonary artery hypertension (PAH) in infants is rare presentation without congenital heart disease (CHD). Cardiac beriberi is often a missed diagnosis and is still common. Thiamine supplements in unexplained congestive heart failure (CHF) with severe PAH in a patient from poor socio economic (SE) status may be life saving. Materials and methods: A total of 25 infants (male 18, female 7) were found to have unexplained severe PAH during period of June 2012 to June 2015 were included. All infants were exclusively breast fed belonging to low SE strata with their mothers from predominant rice eating population. Infants with CHD were excluded. Presentation was poor feeding, excessive cry and/or respiratory distress. 2D Echo done showed severe PAH and RV dysfunction in all; 2 patients had associated pericardial and pleural effusion. Diagnosis of cardiac beriberi was made and thiamine supplement were started immediately. No other PAH medications were given. Results: The average age of presentation was 3.5 months (range 1-6 months); weight 4.3 kg (2.8-6.5 kg). Arterial blood gas (ABG) analysis showed high lactate levels (mean 6.4, range 3.4-17 mmol/l) at presentation. Mean PA pressures were 74 mmHg (range 50-110 mmHg) at admission. The lactate levels were higher in infants less than three-month age (n = 10) when compared with older infants (n = 15) between 3-month and 6-month age group (lactate 9.6 mmol/l vs 4.2 mmol/l respectively, p < 0.05). The infants presenting before three months had severe CHF and two infants presented with acute gasping state with severe lactic acidosis requiring mechanical ventilation. The response of thiamine supplement was rapid, ABG i n d i a n h e a r t j o u r n a l 7 9 ( 2 0 1 5 ) s 9 9 -s 1 0 7 S102
